Clinical Trial Update: Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD) [NA]

View source ↗

Summary

Observational registry study of FIREHAWK DES for coronary artery disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Firehawk DES (firehawk drug-eluting stent)

Snippet

Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2016-03-17